The US Food and Drug Administration (FDA) has granted NeuroRx and Relief Therapeutics an Investigational New Drug (IND) permission to test RLF-100 for inhaled use in patients with moderate and severe coronavirus 2019 (COVID-19) in order to prevent progression to respiratory failure.  The first phase will commence with patients hospitalized for severe COVID-19 who do not yet […]

Eli Lilly and the NIH are about to start a first-of-its-kind trial that researchers and developers have talked about for months as a way of providing temporary immunity to the most at-risk populations. Lilly announced this morning that it will start a 2,400-person trial with the National Institute for Allergy and Infectious Diseases to test […]

Towards the end of 2019, the National Institutes of Health (NIH) organized a Pandemic Preparedness Challenge that aimed to assess the potential response to an emerging disease outbreak, such as a new strain of influenza. In one of the resulting publications from the exercise, the role that a novel technology, Arrayed Imaging Reflectometry (AIR™), could play in quickly […]